Doximity revenue and financials
In the fiscal year ended March 2026, Doximity reported revenue of $644.86M (+13.05% year over year). Net income was $196.05M, a net margin of 30.4%.
Fiscal year ending in March. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +13.05%
- FY to Mar 2026 vs FY to Mar 2025
- Net income growth
- −12.16%
- FY to Mar 2026 vs FY to Mar 2025
- Net margin
- 30.4%
- FY to Mar 2025: 39.1%
How Doximity is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 25.5% a year on average over the last 5 years
Compound annual growth rate: from $206.9M in 2021 to $644.86M in 2026.
Revenue has grown for 7 fiscal years in a row
Each fiscal year compared with the one before, up to 2026.
Operating margin rose from 30.0% to 34.4%
Operating income over revenue, 2023 → 2026: 4.4 percentage points.
Profits turn into cash: free cash flow equal to 138% of net income
Totals for fiscal years 2024–2026: free cash flow $783.67M, net income $566.82M.
Shares outstanding up 109.2% in 5 years
Average diluted shares, 2021 → 2026: with more shares, each one represents a smaller stake in the company (dilution).
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | FY to Mar 2026 | FY to Mar 2025 | FY to Mar 2024 | FY to Mar 2023 | FY to Mar 2022 | FY to Mar 2021 | FY to Mar 2020 | FY to Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Total revenue | 645 | 570 | 475 | 419 | 344 | 207 | 116 | 85.7 |
| Cost of revenue | 70.3 | 55.9 | 50.7 | 53.5 | 39.8 | 31.2 | 14.9 | 10.9 |
| Gross profit | 575 | 515 | 425 | 366 | 304 | 176 | 101 | 74.8 |
| Selling, general and administrative | 222 | 191 | 171 | 160 | 128 | 78.0 | 45.7 | 40.4 |
| Research and development | 131 | 93.0 | 82.0 | 80.2 | 62.4 | 43.9 | 32.4 | 27.5 |
| Operating income | 222 | 231 | 172 | 126 | 114 | 53.8 | 23.3 | 6.9 |
| EBIT | 222 | 231 | 172 | 126 | 114 | 53.8 | 23.3 | 6.9 |
| EBITDA | 229 | 236 | 177 | 131 | 115 | 55.3 | 23.5 | 7.1 |
| Pre-tax income | 250 | 264 | 185 | 133 | 114 | 57.8 | 23.5 | 7.9 |
| Income tax | 54.0 | 40.4 | 37.6 | 20.3 | -40.8 | 7.6 | -6.2 | 0.1 |
| Net income | 196 | 223 | 148 | 113 | 155 | 50.2 | 29.7 | 7.8 |
| Net income to common shareholders | 196 | 223 | 148 | 113 | 133 | 21.6 | 10.8 | 0.6 |
| Basic EPS | 1.05 | 1.19 | 0.78 | 0.58 | 0.82 | 0.29 | 0.16 | 0.01 |
| Diluted EPS | 0.98 | 1.11 | 0.72 | 0.53 | 0.70 | 0.23 | 0.13 | 0.01 |
| Average shares (basic) | 187 | 187 | 190 | 193 | 163 | 74.3 | 66.8 | 64.3 |
| Average shares (diluted) | 199 | 201 | 206 | 213 | 191 | 95.1 | 81.7 | 75.7 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 175 | 157 | 145 | 185 | 169 | 146 | 138 | 169 | 137 | 127 | 118 | 135 |
| Cost of revenue | 25.3 | 23.7 | 19.4 | 18.7 | 16.4 | 15.8 | 14.5 | 14.2 | 13.7 | 13.6 | 12.6 | 12.2 |
| Gross profit | 149 | 133 | 126 | 166 | 152 | 130 | 124 | 154 | 123 | 113 | 105 | 123 |
| Selling, general and administrative | 63.3 | 60.7 | 55.5 | 59.8 | 56.9 | 48.2 | 50.2 | 52.0 | 44.2 | 44.3 | 43.3 | 44.1 |
| Research and development | 42.0 | 38.5 | 39.1 | 34.6 | 30.2 | 26.8 | 24.8 | 22.4 | 23.2 | 22.6 | 20.1 | 19.9 |
| Operating income | 43.9 | 33.7 | 31.4 | 72.0 | 65.0 | 55.1 | 48.8 | 80.0 | 55.7 | 46.3 | 42.0 | 59.0 |
| EBIT | 43.9 | 33.7 | 31.4 | 72.0 | 65.0 | 55.1 | 48.8 | 80.0 | 55.7 | 46.3 | 42.0 | 59.0 |
| EBITDA | 46.0 | 35.8 | 33.4 | 74.1 | 66.7 | 56.2 | 50.1 | 81.2 | 56.9 | 47.5 | 43.3 | 60.2 |
| Pre-tax income | 50.3 | 40.4 | 32.1 | 80.8 | 72.9 | 64.1 | 58.4 | 89.8 | 62.2 | 53.2 | 48.0 | 63.0 |
| Income tax | 15.6 | 16.0 | 13.0 | 19.2 | 10.9 | 10.8 | -4.1 | 14.6 | 18.0 | 11.8 | 7.3 | 15.1 |
| Net income | 34.7 | 24.3 | 19.1 | 61.6 | 62.1 | 53.3 | 62.5 | 75.2 | 44.2 | 41.4 | 40.6 | 48.0 |
| Net income to common shareholders | 34.7 | 24.3 | 19.1 | 61.6 | 62.1 | 53.3 | 62.5 | 75.2 | 44.2 | 41.4 | 40.6 | 48.0 |
| Basic EPS | 0.19 | 0.13 | 0.10 | 0.33 | 0.33 | 0.28 | 0.33 | 0.40 | 0.24 | 0.22 | 0.22 | 0.26 |
| Diluted EPS | 0.18 | 0.13 | 0.10 | 0.31 | 0.31 | 0.27 | 0.31 | 0.37 | 0.22 | 0.21 | 0.20 | 0.24 |
| Average shares (basic) | 179 | 183 | 185 | 187 | 188 | 188 | 188 | 187 | 186 | 186 | 187 | 186 |
| Average shares (diluted) | 188 | 191 | 195 | 199 | 201 | 201 | 203 | 202 | 200 | 199 | 201 | 200 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | FY to Mar 2026 | FY to Mar 2025 | FY to Mar 2024 | FY to Mar 2023 | FY to Mar 2022 | FY to Mar 2021 | FY to Mar 2020 | FY to Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 1,124 | 1,264 | 1,079 | 1,137 | 991 | 252 | 139 | 86.6 |
| Current assets | 944 | 1,089 | 913 | 975 | 904 | 209 | 123 | 83.4 |
| Cash and equivalents | 219 | 210 | 96.8 | 158 | 113 | 66.4 | 48.4 | 33.6 |
| Short-term investments | 529 | 706 | 666 | 683 | 685 | 76.1 | 38.0 | 28.7 |
| Receivables | 152 | 136 | 107 | 112 | 84.6 | 51.3 | 26.4 | 15.3 |
| Net property, plant and equipment | 25.2 | 22.5 | 24.7 | 25.1 | 9.6 | 8.9 | 7.1 | 1.4 |
| Goodwill | 85.0 | 67.9 | 67.9 | 67.9 | 18.9 | 18.9 | — | — |
| Other intangible assets | 35.3 | 23.1 | 27.3 | 31.8 | 7.9 | 9.6 | 0.4 | 0.4 |
| Current liabilities | 155 | 156 | 147 | 140 | 111 | 102 | 55.7 | 37.8 |
| Accounts payable | 4.0 | 1.4 | 2.3 | 1.3 | 0.5 | 1.5 | 1.4 | 0.9 |
| Total debt | 10.2 | 12.4 | 14.5 | 15.6 | 1.1 | 1.3 | 2.3 | — |
| Total liabilities | 173 | 182 | 178 | 171 | 113 | 104 | 56.3 | 38.1 |
| Total equity (incl. minority) | 951 | 1,083 | 901 | 966 | 879 | 148 | 82.6 | 48.5 |
| Retained earnings | -51.1 | 187 | 80.0 | 218 | 191 | 36.3 | -13.9 | -43.6 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1,092 | 1,084 | 1,124 | 1,157 | 1,257 | 1,204 | 1,264 | 1,172 | 1,119 | 1,073 | 1,079 | 1,001 |
| Current assets | 922 | 914 | 944 | 993 | 1,092 | 1,034 | 1,089 | 1,013 | 958 | 908 | 913 | 841 |
| Cash and equivalents | 219 | 274 | 219 | 64.8 | 169 | 137 | 210 | 165 | 184 | 111 | 96.8 | 123 |
| Short-term investments | 495 | 414 | 529 | 670 | 709 | 704 | 706 | 680 | 621 | 639 | 666 | 587 |
| Receivables | 173 | 184 | 152 | 164 | 141 | 151 | 136 | 145 | 131 | 128 | 107 | 102 |
| Net property, plant and equipment | 26.2 | 26.0 | 25.2 | 24.6 | 23.7 | 22.7 | 22.5 | 22.8 | 22.6 | 24.7 | 24.7 | 24.6 |
| Goodwill | 85.0 | 85.0 | 85.0 | 85.0 | 85.0 | 67.9 | 67.9 | 67.9 | 67.9 | 67.9 | 67.9 | 67.9 |
| Other intangible assets | 31.4 | 33.4 | 35.3 | 37.3 | 39.1 | 22.1 | 23.1 | 24.1 | 25.2 | 26.3 | 27.3 | 28.4 |
| Current liabilities | 145 | 150 | 155 | 150 | 140 | 160 | 156 | 116 | 132 | 135 | 147 | 105 |
| Accounts payable | 6.3 | 6.5 | 4.0 | 4.8 | 4.4 | 2.0 | 1.4 | 1.6 | 2.8 | 1.7 | 2.3 | 1.9 |
| Total debt | 9.1 | 9.7 | 10.2 | 10.7 | 11.3 | 11.8 | 12.4 | 12.9 | 13.5 | 14.0 | 14.5 | — |
| Total liabilities | 163 | 168 | 173 | 178 | 162 | 179 | 182 | 141 | 157 | 160 | 178 | 136 |
| Total equity (incl. minority) | 928 | 916 | 951 | 979 | 1,096 | 1,026 | 1,083 | 1,031 | 961 | 914 | 901 | 865 |
| Retained earnings | -139 | -119 | -51.1 | 21.0 | 158 | 117 | 187 | 151 | 95.2 | 72.9 | 80.0 | 61.0 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | FY to Mar 2026 | FY to Mar 2025 | FY to Mar 2024 | FY to Mar 2023 | FY to Mar 2022 | FY to Mar 2021 | FY to Mar 2020 | FY to Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 326 | 273 | 184 | 180 | 127 | 83.0 | 26.2 | 15.3 |
| Depreciation and amortization | 7.0 | 4.9 | 5.3 | 5.5 | 1.5 | 1.5 | 0.2 | 0.2 |
| Capital expenditure | -9.0 | -6.5 | -0.1 | -1.7 | -1.9 | -0.2 | -0.3 | -0.1 |
| Investing cash flow | 147 | -29.3 | 31.2 | -59.9 | -641 | -70.4 | -13.1 | -9.1 |
| Financing cash flow | -464 | -131 | -277 | -74.5 | 560 | 5.4 | 1.7 | 1.0 |
| Share repurchases | -472 | -149 | -287 | -89.1 | -3.5 | -2.0 | 0.0 | — |
| Net change in cash | 9.6 | 113 | -61.2 | 45.2 | 46.4 | 18.0 | 14.8 | 7.2 |
| Free cash flow | 326 | 273 | 184 | 178 | 125 | — | — | — |
| Levered free cash flow | 255 | 217 | 164 | 138 | 82.1 | 63.8 | 19.1 | — |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 93.3 | 42.0 | 110 | 60.9 | 93.9 | 62.1 | 98.5 | 65.2 | 68.3 | 41.2 | 63.9 | 50.1 |
| Depreciation and amortization | 2.1 | 2.1 | 2.0 | 2.1 | 1.8 | 1.1 | 1.2 | 1.2 | 1.2 | 1.3 | 1.2 | 1.2 |
| Capital expenditure | -2.0 | -0.1 | -2.3 | -2.4 | -2.4 | — | — | — | — | — | 0.0 | -0.0 |
| Investing cash flow | -84.0 | 113 | 138 | 38.2 | -31.7 | 2.7 | -24.5 | -58.9 | 24.2 | 29.9 | -76.2 | 40.1 |
| Financing cash flow | -64.2 | -101 | -93.2 | -204 | -30.2 | -137 | -29.7 | -25.2 | -19.7 | -56.5 | -14.1 | -75.5 |
| Share repurchases | -66.4 | -98.6 | -98.0 | -206 | -34.5 | -134 | -37.6 | -28.9 | -28.8 | -53.6 | -19.2 | -78.0 |
| Net change in cash | -55.0 | 54.4 | 154 | -104 | 32.0 | -72.4 | 44.3 | -19.0 | 72.8 | 14.7 | -26.3 | 14.7 |
| Free cash flow | 93.3 | 41.9 | 110 | 60.9 | 93.9 | 62.1 | 98.5 | 65.2 | 68.3 | 41.2 | 63.9 | 50.0 |
| Levered free cash flow | 86.3 | 28.9 | 130 | 47.8 | 33.9 | 44.4 | 88.6 | 40.0 | 58.6 | 29.6 | 64.7 | 35.1 |
Financial statements of similar companies
Companies in the group: same industry, similar size
